Home Tags Cancer: Skin

Tag: Cancer: Skin

A short course of calcipotriol plus 5-fluorouracil treatment for actinic keratosis is associated with induction of robust T cell immunity and reduced development of squamous cell carcinoma within three years

Topical Immunotx for Actinic Keratosis May Prevent Cancer

Fewer patients treated with calcipotriol plus 5-FU developed SCC on treated face, scalp within three years
For patients with advanced Merkel cell carcinoma

Tumor Control Durable With Pembrolizumab in Merkel Cell Cancer

28 of 50 advanced MCC patients responded; 24-month overall survival rate was 68.7 percent
U.S. states with more physicians and a larger percentage of non-Hispanic whites have worse melanoma survival

Melanoma Survival Varies Among U.S. States

Worse survival in states with more physicians; higher death rates in states with lower incidence
Undergoing health care screening practices is associated with an increased likelihood of being diagnosed with skin cancer

Health Care Screening Practices Impact Skin Cancer Diagnosis

Likelihood of being diagnosed with skin cancer increased for those undergoing health care screening
The American Academy of Pediatrics has developed its first guideline for the management of infantile hemangiomas; the clinical practice guideline was published online Dec. 24 in Pediatrics.

New AAP Guideline Available for Infantile Hemangioma Treatment

Early intervention and/or referral recommended for potentially problematic infantile hemangiomas
New guidelines have been released for the treatment of primary cutaneous melanoma

AAD Releases New Guidelines for the Tx of Cutaneous Melanoma

Guidelines recommend surgical excision as primary treatment modality, emphasize individualized care
Libtayo (cemiplimab-rwlc) injection has been approved by the U.S. Food and Drug Administration to treat metastatic cutaneous squamous cell carcinoma

FDA Approves New Treatment for Squamous Cell Carcinoma

Libtayo is the sixth FDA-approved immune checkpoint inhibitor targeting the PD-1 pathway
Checkpoint blockade immunotherapy is associated with significant increases in overall survival in a real-world population of patients undergoing treatment for melanoma brain metastases

Novel Immunotherapy May Up Survival in Melanoma Brain Mets

Findings in patients receiving checkpoint blockade immunotherapy for melanoma brain metastases
For patients with primary basal cell carcinoma

Review: Treatments for Primary Basal Cell Carcinoma Compared

Similarly low recurrence rates for excision, Mohs sx, curettage and diathermy, external-beam radiation
For patients with melanoma and untreated brain metastases

Nivolumab + Ipilimumab Shows Efficacy for Untreated Brain Mets

Findings from open-label, phase 2 study in patients with melanoma and untreated brain metastases